EPCAM and metastatic malignant neoplasm: Taking into account that EpCAM-positive CTCs isolated from patients with metastatic cancer present a hybrid epithelial-mesenchymalphenotype [26, 59], we might suppose that an EpCAM-negative population will express EMT markers at a higher rate.